{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:25:56Z","timestamp":1792801556477,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.forsciint.2011.04.008","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T14:21:43Z","timestamp":1305901303000},"page":"184-188","source":"Crossref","is-referenced-by-count":40,"title":["Serotonin toxicity involving MDMA (ecstasy) and moclobemide"],"prefix":"10.1016","volume":"215","author":[{"given":"J.L.","family":"Pilgrim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gerostamoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Woodford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf H.","family":"Drummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2011.04.008_bib0005","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1556-4029.2008.00949.x","article-title":"Involvement of amphetamines in sudden and unexpected death","volume":"54","author":"Pilgrim","year":"2009","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/00048670701449237","article-title":"Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk","volume":"41","author":"Silins","year":"2007","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.forsciint.2011.04.008_bib0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.addbeh.2005.05.025","article-title":"Ecstasy and the concomitant use of pharmaceuticals","volume":"31","author":"Copeland","year":"2006","journal-title":"Addict. Behav."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/02791072.2009.10400671","article-title":"Mediating MDMA-related harm: preloading and post-loading among Ecstasy-using youth","volume":"41","author":"Kelly","year":"2009","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.forsciint.2011.04.008_bib0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1360-0443.2003.00292.x","article-title":"Death following ingestion of MDMA (ecstasy) and moclobemide","volume":"98","author":"Vuori","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2011.04.008_bib0030","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/S0140-6736(00)02276-5","article-title":"MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks","volume":"355","author":"Boot","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.forsciint.2011.04.008_bib0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.forsciint.2003.10.021","article-title":"Death following acute poisoning by moclobemide","volume":"140","author":"Giroud","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0040","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.forsciint.2011.04.008_bib0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","article-title":"Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity","volume":"95","author":"Gillman","year":"2005","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0050","unstructured":"Australian Bureau of Criminal Intelligence (ABCI) Australian illicit drug report 2001\u201302 (2003)."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0055","unstructured":"Australian Institute of Health and Welfare (AIHW), 2004 national drug strategy household survey-first results. AIHW, Canberra (2005)."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jat\/18.3.134","article-title":"Capillary gas chromatographic drug screen for use in forensic toxicology","volume":"18","author":"Drummer","year":"1994","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuroscience.2007.01.012","article-title":"The effects of co-administration of 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats","volume":"146","author":"Stanley","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.forsciint.2011.04.008_bib0070","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2005.01.093","article-title":"Effects of 3 4-methylenedioxymethamphetamine (MDMA, \u2018Ecstasy\u2019) and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide","volume":"1041","author":"Freezer","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0075","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-3057(01)00711-0","article-title":"Recreational Ecstasy\/MDMA, the serotonin syndrome, and serotonergic neurotoxicity","volume":"71","author":"Parrott","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0080","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0085","unstructured":"Centres of Disease Control and Prevention (CDC), Emergency department visits involving nonmedical use of selected prescription drugs. Morbidity and Mortality Weekly Report (MMWR), (2010) vol 59."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/ajem.2003.50028","article-title":"Multiple toxicity from 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d)","volume":"21","author":"Greene","year":"2003","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0095","unstructured":"Kaye S, McKetin, R. Cardiotoxicity associated with methamphetamine use and signs of cardiovascular pathology among methamphetamine users. National Drug Abuse Research Centre (2005)."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0100","series-title":"Drugs Abuse Handbook","author":"Karch","year":"1998"},{"key":"10.1016\/j.forsciint.2011.04.008_bib0105","article-title":"The serotonin syndrome","volume":"62","author":"Bijl","year":"2004","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.forsciint.2004.02.012","article-title":"Preanalytic aspects in postmortem toxicology","volume":"142","author":"Skopp","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.forsciint.2004.02.011","article-title":"Postmortem toxicology","volume":"142","author":"Madea","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0379-0738(01)00397-8","article-title":"Drugs in postmortem adipose tissues: evidence of antemortem deposition","volume":"121","author":"Levisky","year":"2001","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0125","unstructured":"Koski A, Interpretation of postmortem toxicology results: Pharmacogenetics and drug-alcohol interaction.. PhD Thesis, University of Helsinki, Helsinki, Finland (2005)."},{"key":"10.1016\/j.forsciint.2011.04.008_bib0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.forsciint.2004.02.013","article-title":"Postmortem toxicology of drugs of abuse","volume":"142","author":"Drummer","year":"2004","journal-title":"Forensic Sci. Int."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073811001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073811001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T20:00:50Z","timestamp":1543780850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073811001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":26,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0379073811001757"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2011.04.008","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}